Name	Author Type	Article Type	pmid	Journal	Year	Article title	Author affiliation
Sihem Cheloufi	First	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Ulrich Elling	2	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Barbara Hopfgartner	3	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Youngsook L Jung	4	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Biomedical Informatics; Harvard Medical School; Boston; Massachusetts 02115; USA.
Jernej Murn	5	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Cell Biology; Harvard Medical School; Boston; Massachusetts 02115; USA.
Maria Ninova	6	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	California Institute of Technology; Division of Biology and Biological Engineering; Pasadena; California 91125; USA.
Maria Hubmann	7	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Aimee I Badeaux	8	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Cell Biology; Harvard Medical School; Boston; Massachusetts 02115; USA.
Cheen Euong Ang	9	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute for Stem Cell Biology and Regenerative Medicine; Department of Pathology and Department of Bioengineering; Stanford University; Stanford; California 94305; USA.
Danielle Tenen	10	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute; Cambridge; Massachusetts 02138; USA.
Daniel J Wesche	11	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Nadezhda Abazova	12	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Max Hogue	13	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Nilgun Tasdemir	14	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Memorial Sloan Kettering Cancer Center; New York; New York 10065; USA.
Justin Brumbaugh	15	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Philipp Rathert	16	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Julian Jude	17	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Francesco Ferrari	18	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Biomedical Informatics; Harvard Medical School; Boston; Massachusetts 02115; USA.
Andres Blanco	19	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Cell Biology; Harvard Medical School; Boston; Massachusetts 02115; USA.
Michaela Fellner	20	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Daniel Wenzel	21	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Marietta Zinner	22	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Simon E Vidal	23	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	The Helen L. and Martin S. Kimmel Center for Biology and Medicine; Skirball Institute of Biomolecular Medicine; Department of Cell Biology; NYU School of Medicine; New York; New York 10016; USA.
Oliver Bell	24	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Matthias Stadtfeld	25	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	The Helen L. and Martin S. Kimmel Center for Biology and Medicine; Skirball Institute of Biomolecular Medicine; Department of Cell Biology; NYU School of Medicine; New York; New York 10016; USA.
Howard Y Chang	26	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Howard Hughes Medical Institute; Chevy Chase; Maryland 20815; USA.
Genevieve Almouzni	27	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Centre de Recherche; Institut Curie; 75248 Paris; France.
Scott W Lowe	28	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Howard Hughes Medical Institute; Chevy Chase; Maryland 20815; USA.
John Rinn	29	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Stem Cell and Regenerative Biology and Harvard Stem Cell Institute; Cambridge; Massachusetts 02138; USA.
Marius Wernig	30	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute for Stem Cell Biology and Regenerative Medicine; Department of Pathology and Department of Bioengineering; Stanford University; Stanford; California 94305; USA.
Alexei Aravin	31	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	California Institute of Technology; Division of Biology and Biological Engineering; Pasadena; California 91125; USA.
Yang Shi	32	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Cell Biology; Harvard Medical School; Boston; Massachusetts 02115; USA.
Peter J Park	33	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Biomedical Informatics; Harvard Medical School; Boston; Massachusetts 02115; USA.
Josef M Penninger	34	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Johannes Zuber	35	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); A-1030 Vienna; Austria.
Konrad Hochedlinger	Corresponding	Journal Article	26659182	Nature	2015	The histone chaperone CAF-1 safeguards somatic cell identity.	Department of Molecular Biology; Cancer Center and Center for Regenerative Medicine; Massachusetts General Hospital; Boston; Massachusetts 02114; USA.
Bin Xia Yang	First	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Chadi A El Farran	2	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biological Sciences; National University of Singapore; Singapore 117543; Singapore.
Hong Chao Guo	3	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	College of Life Sciences; Nankai University; Tianjin 300071; China.
Tao Yu	4	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biological Sciences; National University of Singapore; Singapore 117543; Singapore.
Hai Tong Fang	5	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Hao Fei Wang	6	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biological Sciences; National University of Singapore; Singapore 117543; Singapore.
Sharon Schlesinger	7	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Department of Biochemistry and Molecular Biophysics; Columbia University; New York; NY 10032; USA; Department of Microbiology and Immunology; Columbia University; New York; NY 10032; USA.
Yu Fen Samantha Seah	8	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Germaine Yen Lin Goh	9	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Membrane Traffic Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Suat Peng Neo	10	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Quantitative Proteomics Group; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Yinghui Li	11	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Division of Cancer Genetics and Therapeutics; Laboratory of NF-ÎºB Signaling; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore.
Matthew C Lorincz	12	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Department of Medical Genetics; Life Sciences Institute; University of British Columbia; Vancouver; BC V6T 1Z3; Canada.
Vinay Tergaonkar	13	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Division of Cancer Genetics and Therapeutics; Laboratory of NF-ÎºB Signaling; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biochemistry; Yong Loo Lin School of Medicine; National University of Singapore; Singapore 119077; Singapore.
Tit-Meng Lim	14	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Department of Biological Sciences; National University of Singapore; Singapore 117543; Singapore.
Lingyi Chen	15	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	College of Life Sciences; Nankai University; Tianjin 300071; China.
Jayantha Gunaratne	16	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Quantitative Proteomics Group; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Anatomy; Yong Loo Lin School of Medicine; National University of Singapore; Singapore 117597; Singapore.
James J Collins	17	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Department of Biological Engineering; Synthetic Biology Center; Institute for Medical Engineering and Science; Massachusetts Institute of Technology; Cambridge; MA 02139; USA; Broad Institute of MIT and Harvard; Cambridge; MA 02139; USA; Wyss Institute for Biologically Inspired Engineering; Harvard University; Boston; MA 02115; USA; Howard Hughes Medical Institute; Boston; MA 02115; USA.
Stephen P Goff	18	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Department of Biochemistry and Molecular Biophysics; Columbia University; New York; NY 10032; USA; Department of Microbiology and Immunology; Columbia University; New York; NY 10032; USA; Howard Hughes Medical Institute; New York; NY 10032; USA.
George Q Daley	19	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Howard Hughes Medical Institute; Boston; MA 02115; USA; Stem Cell Transplantation Program; Division of Pediatric Hematology/Oncology; Boston Children's Hospital and Dana-Farber Cancer Institute; Boston; MA 02115; USA; Department of Biological Chemistry and Molecular Pharmacology; Harvard Medical School; Boston; MA 02115; USA; Harvard Stem Cell Institute; Boston; MA 02115; USA; Manton Center for Orphan Disease Research; Boston; MA 02115; USA.
Hu Li	20	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Center for Individualized Medicine; Department of Molecular Pharmacology & Experimental Therapeutics; Mayo Clinic; Rochester; MNÂ 55905; USA.
Frederic A Bard	21	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Membrane Traffic Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biochemistry; Yong Loo Lin School of Medicine; National University of Singapore; Singapore 119077; Singapore.
Yuin-Han Loh	Corresponding	Journal Article	26365490	Cell	2015	Systematic identification of factors for provirus silencing in embryonic stem cells.	Epigenetics and Cell Fates Laboratory; A(â)STAR Institute of Molecular and Cell Biology; 61 Biopolis Drive Proteos; Singapore 138673; Singapore; Department of Biological Sciences; National University of Singapore; Singapore 117543; Singapore. Electronic address: yhloh@imcb.a-star.edu.sg.
Liangran Zhang	First	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Molecular and Cellular Biology; Harvard University; Cambridge; Massachusetts 02138; USA.
Shunxin Wang	2	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Molecular and Cellular Biology; Harvard University; Cambridge; Massachusetts 02138; USA.
Shen Yin	3	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Molecular and Cellular Biology; Harvard University; Cambridge; Massachusetts 02138; USA.
Soogil Hong	4	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Life Science; Chung-Ang University; Seoul 156-756; South Korea.
Keun P Kim	5	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Life Science; Chung-Ang University; Seoul 156-756; South Korea.
Nancy Kleckner	Corresponding	Journal Article	25043020	Nature	2014	Topoisomerase II mediates meiotic crossover interference.	Department of Molecular and Cellular Biology; Harvard University; Cambridge; Massachusetts 02138; USA.
C Bassi	First	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
J Ho	2	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
T Srikumar	3	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
R J O Dowling	4	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
C Gorrini	5	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
S J Miller	6	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
T W Mak	7	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
B G Neel	8	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
B Raught	9	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
V Stambolic	Corresponding	Journal Article	23888040	Science	2013	Nuclear PTEN controls DNA repair and sensitivity to genotoxic stress.	Department of Medical Biophysics; University of Toronto; Toronto; Ontario M5G 2M9; Canada.
Ivan Psakhye	First	Journal Article	23122649	Cell	2012	Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair.	Department of Molecular Cell Biology; Max Planck Institute of Biochemistry; Am Klopferspitz 18; 82152 Martinsried; Germany.
Stefan Jentsch	Corresponding	Journal Article	23122649	Cell	2012	Protein group modification and synergy in the SUMO pathway as exemplified in DNA repair.	Department of Molecular Cell Biology; Max Planck Institute of Biochemistry; Am Klopferspitz 18; 82152 Martinsried; Germany.
Paul A Dutchak	First	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Takeshi Katafuchi	2	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Angie L Bookout	3	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Jang Hyun Choi	4	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Ruth T Yu	5	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
David J Mangelsdorf	6	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Steven A Kliewer	Corresponding	Journal Article	22304921	Cell	2012	Fibroblast growth factor-21 regulates PPARÎ³ activity and the antidiabetic actions of thiazolidinediones.	Department of Molecular Biology; University of Texas Southwestern Medical Center; Dallas; TX 75390-9041; USA.
Jessica D Kessler	First	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Kristopher T Kahle	2	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Tingting Sun	3	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Kristen L Meerbrey	4	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Michael R Schlabach	5	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Earlene M Schmitt	6	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Samuel O Skinner	7	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Qikai Xu	8	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Mamie Z Li	9	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Zachary C Hartman	10	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Mitchell Rao	11	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Peng Yu	12	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Rocio Dominguez-Vidana	13	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Anthony C Liang	14	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Nicole L Solimini	15	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Ronald J Bernardi	16	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Bing Yu	17	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Tiffany Hsu	18	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Ido Golding	19	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Ji Luo	20	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
C Kent Osborne	21	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Chad J Creighton	22	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Susan G Hilsenbeck	23	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Rachel Schiff	24	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Chad A Shaw	25	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Stephen J Elledge	26	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Thomas F Westbrook	Corresponding	Journal Article	22157079	Science	2012	A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.	Verna and Marrs McLean Department of Biochemistry and Molecular Biology; Baylor College of Medicine; Houston; TX 77030; USA.
Satoru Yokoyama	First	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Susan L Woods	2	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Glen M Boyle	3	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Lauren G Aoude	4	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Stuart MacGregor	5	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Victoria Zismann	6	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Michael Gartside	7	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Anne E Cust	8	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Rizwan Haq	9	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Mark Harland	10	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
John C Taylor	11	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
David L Duffy	12	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Kelly Holohan	13	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Ken Dutton-Regester	14	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Jane M Palmer	15	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Vanessa Bonazzi	16	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Mitchell S Stark	17	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Judith Symmons	18	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Matthew H Law	19	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Christopher Schmidt	20	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Cathy Lanagan	21	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Linda O'Connor	22	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Elizabeth A Holland	23	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Helen Schmid	24	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Judith A Maskiell	25	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Jodie Jetann	26	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Megan Ferguson	27	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Mark A Jenkins	28	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Richard F Kefford	29	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Graham G Giles	30	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Bruce K Armstrong	31	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Joanne F Aitken	32	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
John L Hopper	33	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
David C Whiteman	34	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Paul D Pharoah	35	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Douglas F Easton	36	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Alison M Dunning	37	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Julia A Newton-Bishop	38	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Grant W Montgomery	39	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Nicholas G Martin	40	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Graham J Mann	41	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
D Timothy Bishop	42	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Hensin Tsao	43	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Jeffrey M Trent	44	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
David E Fisher	45	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Nicholas K Hayward	46	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Kevin M Brown	Corresponding	Journal Article	22080950	Nature	2011	A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.	Department of Dermatology; Cutaneous Biology Research Center; Massachusetts General Hospital; Harvard Medical School; Massachusetts 02114; USA.
Liuqing Yang	First	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Chunru Lin	2	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Wen Liu	3	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Jie Zhang	4	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Kenneth A Ohgi	5	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Jonathan D Grinstein	6	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Pieter C Dorrestein	7	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Michael G Rosenfeld	Corresponding	Journal Article	22078878	Cell	2011	ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.	Howard Hughes Medical Institute; University of California; San Diego; School of Medicine; 9500 Gilman Drive; La Jolla; CA 92093-0648; USA.
Changwon Kho	First	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Ahyoung Lee	2	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Dongtak Jeong	3	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Jae Gyun Oh	4	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Antoine H Chaanine	5	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Eddy Kizana	6	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Woo Jin Park	7	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Roger J Hajjar	Corresponding	Journal Article	21900893	Nature	2011	SUMO1-dependent modulation of SERCA2a in heart failure.	Cardiovascular Research Center; Mount Sinai School of Medicine; 1 Gustave L. Levy Place; Box 1030; New York; New York 10029; USA.
Wendy Huang	First	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Serena Ghisletti	2	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Kaoru Saijo	3	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Meghal Gandhi	4	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Myriam Aouadi	5	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Greg J Tesz	6	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Dawn X Zhang	7	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Joyee Yao	8	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Michael P Czech	9	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Bruce L Goode	10	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Michael G Rosenfeld	11	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
Christopher K Glass	Corresponding	Journal Article	21331046	Nature	2011	Coronin 2A mediates actin-dependent de-repression of inflammatory response genes.	Department of Cellular and Molecular Medicine; University of California; San Diego; 9500 Gilman Drive; La Jolla; California 92093-0651; USA.
David Ribet	First	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
MÃ©lanie Hamon	2	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Edith Gouin	3	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Marie-Anne Nahori	4	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Francis Impens	5	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
HÃ©lÃ¨ne Neyret-Kahn	6	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Kris Gevaert	7	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
JoÃ«l Vandekerckhove	8	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Anne Dejean	9	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Pascale Cossart	Corresponding	Journal Article	20414307	Nature	2010	Listeria monocytogenes impairs SUMOylation for efficient infection.	Institut Pasteur; UnitÃ© des Interactions BactÃ©ries-Cellules; DÃ©partement de Biologie Cellulaire et Infection; F-75015 Paris; France.
Xiao-Wei Zhang	First	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Xiao-Jing Yan	2	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Zi-Ren Zhou	3	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Fei-Fei Yang	4	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Zi-Yu Wu	5	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Hong-Bin Sun	6	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Wen-Xue Liang	7	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Ai-Xin Song	8	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
ValÃ©rie Lallemand-Breitenbach	9	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Marion Jeanne	10	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Qun-Ye Zhang	11	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Huai-Yu Yang	12	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Qiu-Hua Huang	13	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Guang-Biao Zhou	14	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Jian-Hua Tong	15	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Yan Zhang	16	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Ji-Hui Wu	17	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Hong-Yu Hu	18	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Hugues de ThÃ©	19	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Sai-Juan Chen	20	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Zhu Chen	Corresponding	Journal Article	20378816	Science	2010	Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.	State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Rui Jin Hospital affiliated to Shanghai Jiao Tong University School of Medicine; 197 Rui Jin Road II; Shanghai 200025; China.
Yaron Galanty	First	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Rimma Belotserkovskaya	2	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Julia Coates	3	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Sophie Polo	4	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Kyle M Miller	5	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Stephen P Jackson	Corresponding	Journal Article	20016603	Nature	2009	Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks.	The Wellcome Trust and Cancer Research UK Gurdon Institute; and Department of Biochemistry; University of Cambridge; Tennis Court Road; Cambridge CB2 1QN; UK.
Joanna R Morris	First	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Chris Boutell	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Melanie Keppler	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Ruth Densham	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Daniel Weekes	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Amin Alamshah	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Laura Butler	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Yaron Galanty	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Laurent Pangon	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Tai Kiuchi	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Tony Ng	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Ellen Solomon	Corresponding	Journal Article	20016594	Nature	2009	The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress.	Department of Medical and Molecular Genetics; King's College London; Guy's Medical School Campus; London SE1 9RT; UK. jo.morris@genetics.kcl.ac.uk
Srinivasa Subramaniam	First	Journal Article	19498170	Science	2009	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Solomon H. Snyder Department of Neuroscience; Johns Hopkins University School of Medicine; 725 North Wolfe Street; Baltimore; MD 21205; USA.
Katherine M Sixt	2	Journal Article	19498170	Science	2009	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Solomon H. Snyder Department of Neuroscience; Johns Hopkins University School of Medicine; 725 North Wolfe Street; Baltimore; MD 21205; USA.
Roxanne Barrow	3	Journal Article	19498170	Science	2009	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Solomon H. Snyder Department of Neuroscience; Johns Hopkins University School of Medicine; 725 North Wolfe Street; Baltimore; MD 21205; USA.
Solomon H Snyder	Corresponding	Journal Article	19498170	Science	2009	Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity.	Solomon H. Snyder Department of Neuroscience; Johns Hopkins University School of Medicine; 725 North Wolfe Street; Baltimore; MD 21205; USA.
Dana Branzei	First	Journal Article	19092928	Nature	2008	SUMOylation regulates Rad18-mediated template switch.	IFOM; the FIRC Institute for Molecular Oncology Foundation; IFOM-IEO Campus; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Fabio Vanoli	Corresponding	Journal Article	19092928	Nature	2008	SUMOylation regulates Rad18-mediated template switch.	IFOM; the FIRC Institute for Molecular Oncology Foundation; IFOM-IEO Campus; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Marco Foiani	Corresponding	Journal Article	19092928	Nature	2008	SUMOylation regulates Rad18-mediated template switch.	IFOM; the FIRC Institute for Molecular Oncology Foundation; IFOM-IEO Campus; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Meelad M Dawlaty	First	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Liviu Malureanu	2	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Karthik B Jeganathan	3	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Esther Kao	4	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Claudio Sustmann	5	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Samuel Tahk	6	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Ke Shuai	7	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Rudolf Grosschedl	8	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Jan M van Deursen	Corresponding	Journal Article	18394993	Cell	2008	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	Department of Biochemistry and Molecular Biology; Mayo Clinic College of Medicine; Rochester; MN 55905; USA.
Ivan Ahel	First	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Dragana Ahel	2	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Takahiro Matsusaka	3	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Allison J Clark	4	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Jonathon Pines	5	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Simon J Boulton	6	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Stephen C West	Corresponding	Journal Article	18172500	Nature	2008	Poly(ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins.	Genetic Recombination and; Cancer Research UK London Research Institute; Clare Hall Laboratories; South Mimms; Herts EN6 3LD; UK.
Jinke Cheng	First	Journal Article	17981124	Cell	2007	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Department of Cardiology; The University of Texas MD Anderson Cancer Center; The University of Texas; Houston Health Science Center; Houston; TX 77030; USA.
Xunlei Kang	2	Journal Article	17981124	Cell	2007	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Department of Cardiology; The University of Texas MD Anderson Cancer Center; The University of Texas; Houston Health Science Center; Houston; TX 77030; USA.
Sui Zhang	3	Journal Article	17981124	Cell	2007	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Department of Cardiology; The University of Texas MD Anderson Cancer Center; The University of Texas; Houston Health Science Center; Houston; TX 77030; USA.
Edward T H Yeh	Corresponding	Journal Article	17981124	Cell	2007	SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia.	Department of Cardiology; The University of Texas MD Anderson Cancer Center; The University of Texas; Houston Health Science Center; Houston; TX 77030; USA.
Alberto Carbia-Nagashima	First	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Juan Gerez	2	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Carolina Perez-Castro	3	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Marcelo Paez-Pereda	4	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Susana Silberstein	5	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
GÃ¼nter K Stalla	6	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Florian Holsboer	7	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Eduardo Arzt	Corresponding	Journal Article	17956732	Cell	2007	RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia.	Departamento de FisiologÃ­a y BiologÃ­a Molecular y Celular; Facultad de Ciencias Exactas y Naturales; Universidad de Buenos Aires; Buenos Aires; Argentina.
Sylvain Feliciangeli	First	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
SaÃ¯d Bendahhou	2	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Guillaume Sandoz	3	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Pierre Gounon	4	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Markus Reichold	5	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Richard Warth	6	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Michel Lazdunski	7	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Jacques Barhanin	8	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Florian Lesage	Corresponding	Journal Article	17693262	Cell	2007	Does sumoylation control K2P1/TWIK1 background K+ channels?	Institut de Pharmacologie MolÃ©culaire et Cellulaire; CNRS UMR6097; Institut Paul Hamel; 660; route des lucioles; 06560 Valbonne; France.
Bin Liu	First	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Yonghui Yang	2	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Vasili Chernishof	3	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Rachel R Ogorzalek Loo	4	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Hyunduk Jang	5	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Samuel Tahk	6	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Randy Yang	7	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Sheldon Mink	8	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
David Shultz	9	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Clifford J Bellone	10	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Joseph A Loo	11	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
Ke Shuai	Corresponding	Journal Article	17540171	Cell	2007	Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.	Division of Hematology-Oncology; Department of Medicine; University of California Los Angeles; Los Angeles; CA 90095; USA.
StÃ©phane Martin	First	Journal Article	17486098	Nature	2007	SUMOylation regulates kainate-receptor-mediated synaptic transmission.	MRC Centre for Synaptic Plasticity; Anatomy Department; University Walk; University of Bristol; Bristol; BS8 1TD; UK.
Atsushi Nishimune	2	Journal Article	17486098	Nature	2007	SUMOylation regulates kainate-receptor-mediated synaptic transmission.	MRC Centre for Synaptic Plasticity; Anatomy Department; University Walk; University of Bristol; Bristol; BS8 1TD; UK.
Jack R Mellor	3	Journal Article	17486098	Nature	2007	SUMOylation regulates kainate-receptor-mediated synaptic transmission.	MRC Centre for Synaptic Plasticity; Anatomy Department; University Walk; University of Bristol; Bristol; BS8 1TD; UK.
Jeremy M Henley	Corresponding	Journal Article	17486098	Nature	2007	SUMOylation regulates kainate-receptor-mediated synaptic transmission.	MRC Centre for Synaptic Plasticity; Anatomy Department; University Walk; University of Bristol; Bristol; BS8 1TD; UK.
Dana Branzei	First	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Julie Sollier	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Giordano Liberi	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Xiaolan Zhao	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Daisuke Maeda	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Masayuki Seki	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Takemi Enomoto	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Kunihiro Ohta	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Marco Foiani	Corresponding	Journal Article	17081974	Cell	2006	Ubc9- and mms21-mediated sumoylation counteracts recombinogenic events at damaged replication forks.	FIRC Institute of Molecular Oncology Foundation and Department of Biomedical Sciences and Biotechnology; UniversitÃ  degli Studi di Milano; Via Adamello 16; 20139 Milan; Italy. dana.branzei@ifom-ieo-campus.it
Hannah L Klein	Corresponding	Journal Article	17081966	Cell	2006	A SUMOry of DNA replication: synthesis, damage, and repair.	Department of Biochemistry; New York University School of Medicine; New York; NY 10016; USA. hannah.klein@med.nyu.edu
Fowzan S Alkuraya	First	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Irfan Saadi	2	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Jennifer J Lund	3	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Annick Turbe-Doan	4	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Cynthia C Morton	5	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Richard L Maas	Corresponding	Journal Article	16990542	Science	2006	SUMO1 haploinsufficiency leads to cleft lip and palate.	Division of Genetics; Department of Medicine; Brigham and Women's Hospital and Harvard Medical School; NRB-458; 77 Louis Pasteur; Boston; MA 02115; USA.
Aryaman Shalizi	First	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Brice GaudilliÃ¨re	2	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Zengqiang Yuan	3	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Judith StegmÃ¼ller	4	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Takahiro Shirogane	5	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Qingyuan Ge	6	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Yi Tan	7	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Brenda Schulman	8	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
J Wade Harper	9	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Azad Bonni	Corresponding	Journal Article	16484498	Science	2006	A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation.	Department of Pathology; Harvard Medical School; 77 Louis Pasteur Avenue; Boston; MA 02115; USA.
Sophie Janssens	First	Journal Article	16360037	Cell	2005	PIDD mediates NF-kappaB activation in response to DNA damage.	Department of Biochemistry; University of Lausanne; BIL Biomedical Research Center; Chemin des Boveresses 155; CH-1066 Epalinges; Switzerland.
Antoine Tinel	2	Journal Article	16360037	Cell	2005	PIDD mediates NF-kappaB activation in response to DNA damage.	Department of Biochemistry; University of Lausanne; BIL Biomedical Research Center; Chemin des Boveresses 155; CH-1066 Epalinges; Switzerland.
Saskia Lippens	3	Journal Article	16360037	Cell	2005	PIDD mediates NF-kappaB activation in response to DNA damage.	Department of Biochemistry; University of Lausanne; BIL Biomedical Research Center; Chemin des Boveresses 155; CH-1066 Epalinges; Switzerland.
JÃ¼rg Tschopp	Corresponding	Journal Article	16360037	Cell	2005	PIDD mediates NF-kappaB activation in response to DNA damage.	Department of Biochemistry; University of Lausanne; BIL Biomedical Research Center; Chemin des Boveresses 155; CH-1066 Epalinges; Switzerland.
Zhao-Hui Wu	First	Journal Article	16360026	Cell	2005	PIDD: a switch hitter.	Department of Pharmacology; University of Wisconsin-Madison; 1300 University Avenue; Madison; WI 53706; USA.
Angela Mabb	2	Journal Article	16360026	Cell	2005	PIDD: a switch hitter.	Department of Pharmacology; University of Wisconsin-Madison; 1300 University Avenue; Madison; WI 53706; USA.
Shigeki Miyamoto	Corresponding	Journal Article	16360026	Cell	2005	PIDD: a switch hitter.	Department of Pharmacology; University of Wisconsin-Madison; 1300 University Avenue; Madison; WI 53706; USA.
Gabriel Pascual	First	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Amy L Fong	2	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Sumito Ogawa	3	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Amir Gamliel	4	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Andrew C Li	5	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Valentina Perissi	6	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
David W Rose	7	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Timothy M Willson	8	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Michael G Rosenfeld	9	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Christopher K Glass	Corresponding	Journal Article	16127449	Nature	2005	A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.	Department of Cellular and Molecular Medicine; University of California San Diego; 9500 Gilman Drive; La Jolla; California 92093; USA.
Luca Cardone	First	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Jun Hirayama	2	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Francesca Giordano	3	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Teruya Tamaru	4	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Jorma J Palvimo	5	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Paolo Sassone-Corsi	Corresponding	Journal Article	16109848	Science	2005	Circadian clock control by SUMOylation of BMAL1.	Institut de GÃ©nÃ©tique et de Biologie MolÃ©culaire et Cellulaire; 1 rue Laurent Fries; 67404 Illkirch; Strasbourg; France.
Sindhu Rajan	First	Journal Article	15820677	Cell	2005	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Department of Pediatrics; Institute for Molecular Pediatric Sciences; Pritzker School of Medicine; University of Chicago; 5721 South Maryland Avenue; Chicago; Illinois 60637; USA.
Leigh D Plant	2	Journal Article	15820677	Cell	2005	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Department of Pediatrics; Institute for Molecular Pediatric Sciences; Pritzker School of Medicine; University of Chicago; 5721 South Maryland Avenue; Chicago; Illinois 60637; USA.
Michael L Rabin	3	Journal Article	15820677	Cell	2005	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Department of Pediatrics; Institute for Molecular Pediatric Sciences; Pritzker School of Medicine; University of Chicago; 5721 South Maryland Avenue; Chicago; Illinois 60637; USA.
Margaret H Butler	4	Journal Article	15820677	Cell	2005	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Department of Pediatrics; Institute for Molecular Pediatric Sciences; Pritzker School of Medicine; University of Chicago; 5721 South Maryland Avenue; Chicago; Illinois 60637; USA.
Steve A N Goldstein	Corresponding	Journal Article	15820677	Cell	2005	Sumoylation silences the plasma membrane leak K+ channel K2P1.	Department of Pediatrics; Institute for Molecular Pediatric Sciences; Pritzker School of Medicine; University of Chicago; 5721 South Maryland Avenue; Chicago; Illinois 60637; USA.
Joan S Steffan	First	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Namita Agrawal	2	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Judit Pallos	3	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Erica Rockabrand	4	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Lloyd C Trotman	5	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Natalia Slepko	6	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Katalin Illes	7	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Tamas Lukacsovich	8	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Ya-Zhen Zhu	9	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Elena Cattaneo	10	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Pier Paolo Pandolfi	11	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Leslie Michels Thompson	12	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
J Lawrence Marsh	Corresponding	Journal Article	15064418	Science	2004	SUMO modification of Huntingtin and Huntington's disease pathology.	Department of Psychiatry and Human Behavior; Gillespie 2121; University of California; Irvine; CA 92697; USA.
Tony T Huang	First	Journal Article	14651848	Cell	2003	Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.	Department of Pharmacology; University of Wisconsin-Madison; 301 SMI; 1300 University Avenue; Madison; WI 53706; USA.
Shelly M Wuerzberger-Davis	2	Journal Article	14651848	Cell	2003	Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.	Department of Pharmacology; University of Wisconsin-Madison; 301 SMI; 1300 University Avenue; Madison; WI 53706; USA.
Zhao-Hui Wu	3	Journal Article	14651848	Cell	2003	Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.	Department of Pharmacology; University of Wisconsin-Madison; 301 SMI; 1300 University Avenue; Madison; WI 53706; USA.
Shigeki Miyamoto	Corresponding	Journal Article	14651848	Cell	2003	Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress.	Department of Pharmacology; University of Wisconsin-Madison; 301 SMI; 1300 University Avenue; Madison; WI 53706; USA.
Michael H Kagey	First	Journal Article	12679040	Cell	2003	The polycomb protein Pc2 is a SUMO E3.	Department of Biochemistry and Molecular Genetics; Center for Cell Signaling; University of Virginia; Charlottesville; VA 22908; USA.
Tiffany A Melhuish	2	Journal Article	12679040	Cell	2003	The polycomb protein Pc2 is a SUMO E3.	Department of Biochemistry and Molecular Genetics; Center for Cell Signaling; University of Virginia; Charlottesville; VA 22908; USA.
David Wotton	Corresponding	Journal Article	12679040	Cell	2003	The polycomb protein Pc2 is a SUMO E3.	Department of Biochemistry and Molecular Genetics; Center for Cell Signaling; University of Virginia; Charlottesville; VA 22908; USA.
Richard N Freiman	First	Review	12526789	Cell	2003	Regulating the regulators: lysine modifications make their mark.	Howard Hughes Medical Institute; Department of Molecular and Cell Biology; University of California; Berkeley; CA 94720; USA.
Robert Tjian	Corresponding	Review	12526789	Cell	2003	Regulating the regulators: lysine modifications make their mark.	Howard Hughes Medical Institute; Department of Molecular and Cell Biology; University of California; Berkeley; CA 94720; USA.
Andrea Pichler	First	Journal Article	11792325	Cell	2002	The nucleoporin RanBP2 has SUMO1 E3 ligase activity.	Max-Planck Institute for Biochemistry; Am Klopferspitz 18a; 82152 Martinsried; Germany.
Andreas Gast	2	Journal Article	11792325	Cell	2002	The nucleoporin RanBP2 has SUMO1 E3 ligase activity.	Max-Planck Institute for Biochemistry; Am Klopferspitz 18a; 82152 Martinsried; Germany.
Jacob S Seeler	3	Journal Article	11792325	Cell	2002	The nucleoporin RanBP2 has SUMO1 E3 ligase activity.	Max-Planck Institute for Biochemistry; Am Klopferspitz 18a; 82152 Martinsried; Germany.
Anne Dejean	4	Journal Article	11792325	Cell	2002	The nucleoporin RanBP2 has SUMO1 E3 ligase activity.	Max-Planck Institute for Biochemistry; Am Klopferspitz 18a; 82152 Martinsried; Germany.
Frauke Melchior	Corresponding	Journal Article	11792325	Cell	2002	The nucleoporin RanBP2 has SUMO1 E3 ligase activity.	Max-Planck Institute for Biochemistry; Am Klopferspitz 18a; 82152 Martinsried; Germany.
E S Johnson	First	Journal Article	11572779	Cell	2001	An E3-like factor that promotes SUMO conjugation to the yeast septins.	Department of Biochemistry and Molecular Pharmacology; Thomas Jefferson University; Philadelphia; PA 19107; USA. erica.johnson@mail.tju.edu
A A Gupta	Corresponding	Journal Article	11572779	Cell	2001	An E3-like factor that promotes SUMO conjugation to the yeast septins.	Department of Biochemistry and Molecular Pharmacology; Thomas Jefferson University; Philadelphia; PA 19107; USA. erica.johnson@mail.tju.edu
T Buschmann	First	Journal Article	10892746	Cell	2000	SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.	Derald H Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York; New York 10029; USA.
S Y Fuchs	2	Journal Article	10892746	Cell	2000	SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.	Derald H Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York; New York 10029; USA.
C G Lee	3	Journal Article	10892746	Cell	2000	SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.	Derald H Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York; New York 10029; USA.
Z Q Pan	4	Journal Article	10892746	Cell	2000	SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.	Derald H Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York; New York 10029; USA.
Z Ronai	Corresponding	Journal Article	10892746	Cell	2000	SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.	Derald H Ruttenberg Cancer Center; Mount Sinai School of Medicine; New York; New York 10029; USA.
